Hjem › Skizofreni
Skizofreni kliniske forsøg rekrutterer i USA
106 studier for Skizofreni rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Atlanta, GA22 studier
- Chicago, IL21 studier
- Little Rock, AR19 studier
- Hollywood, FL15 studier
- Boston, MA14 studier
- Houston, TX13 studier
- San Diego, CA13 studier
- New York City, NY13 studier
- Hialeah, FL13 studier
- Austin, TX13 studier
- Garden Grove, CA12 studier
- Germantown, MD11 studier
- Miami, FL10 studier
- Camden, NJ10 studier
- Richardson, TX9 studier
- Cambridge, MA8 studier
- St. Louis, MO8 studier
- Johns Creek, GA8 studier
- Cincinnati, OH8 studier
- Inglewood, CA8 studier
- Anaheim, CA8 studier
- Grand Prairie, TX8 studier
- Philadelphia, PA8 studier
- Los Angeles, CA8 studier
- El Cajon, CA8 studier
- Dallas, TX8 studier
- Springdale, AR7 studier
- West Palm Beach, FL7 studier
- Staten Island, NY7 studier
- Las Vegas, NV7 studier
- Orange, CA7 studier
- Pittsburgh, PA7 studier
- Downey, CA6 studier
- Nashville, TN6 studier
- Orlando, FL6 studier
- Richmond, VA6 studier
- Chino, CA6 studier
- The Bronx, NY6 studier
- Queens, NY6 studier
- Oceanside, CA6 studier
Efter delstat
- Alabama5 studier
- Arizona4 studier
- Arkansas21 studier
- Californien45 studier
- Colorado3 studier
- Connecticut9 studier
- Florida26 studier
- Georgia29 studier
- Illinois26 studier
- Maryland18 studier
- Massachusetts22 studier
- Michigan5 studier
- Minnesota5 studier
- Mississippi3 studier
- Missouri11 studier
- Nebraska6 studier
- Nevada7 studier
- New Jersey13 studier
- New York23 studier
- North Carolina4 studier
- Ohio18 studier
- Oklahoma4 studier
- Pennsylvania15 studier
- Tennessee6 studier
- Texas34 studier
- Virginia6 studier
- Washington8 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT05491538Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 59 · Alle køn · Opdateret 2. okt. 2026 · NCT07853807iTBS to Enhance Social Cognition in People With Psychosis
Rekrutterer
Alder 18 til 39 · Alle køn · Opdateret 1. okt. 2026 · NCT06118268Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
RekruttererFase 4
Alder 12 til 17 · Alle køn · Opdateret 1. okt. 2026 · NCT05648591Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 50 · Alle køn · Opdateret 1. okt. 2026 · NCT07680114Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07101094Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 30. sep. 2026 · NCT06835556A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
RekruttererFase 1
Alder 18 til 55 · Alle køn · Opdateret 28. sep. 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 28. sep. 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 25. sep. 2026 · NCT06229210NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07105098NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07227818Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
RekruttererFase 2
Alder 18 til 60 · Alle køn · Opdateret 23. sep. 2026 · NCT07680946A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 22. sep. 2026 · NCT07424404State Representation in Early Psychosis 2
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 15 til 45 · Alle køn · Opdateret 22. sep. 2026 · NCT07834203A Study of Brenipatide in Adult Participants With Schizophrenia
RekruttererFase 2
Alder 18 til 55 · Alle køn · Opdateret 22. sep. 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
RekruttererFase 1
Alder 18 til 55 · Alle køn · Opdateret 17. sep. 2026 · NCT07734493Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
Rekrutterer
Alder 22 til 65 · Alle køn · Opdateret 16. sep. 2026 · NCT05276050A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 15. sep. 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 9. sep. 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
RekruttererFase 3
Alder 13 til 17 · Alle køn · Opdateret 4. sep. 2026 · NCT07288567Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 21 til 60 · Alle køn · Opdateret 2. sep. 2026 · NCT06058702A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
RekruttererFase 1
Alder 18 til 55 · Alle køn · Opdateret 2. sep. 2026 · NCT07061288Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.